QUEEN'S BENCH DIVISION
ADMINISTRATIVE COURT
Strand, London, WC2A 2LL |
||
B e f o r e :
(Sitting as a Judge of the High Court)
____________________
BENEFICENT SPIRITIST CENTER UNIAO DO VEGETAL |
Claimant |
|
- and - |
||
SECRETARY OF STATE FOR THE HOME DEPARTMENT |
Defendant |
____________________
Mr J Eadie QC and Mr S Pritchard (instructed by the Government Legal Department) for the Defendant
hearing date: 28 June 2017
____________________
Crown Copyright ©
Sir Ross Cranston:
"There is a general paucity of evidence and there have been no controlled clinical studies to establish the safety of hoasca. Those studies that exist have generally been of small numbers of individuals within the context of use in Brazilian Ayahuasca churches. The key issue for the Council is that of formulation and concentration. Unless each batch is tested there is the potential for variability in concentration and strength. Published papers generally report no significant acute deleterious effects on taking hoasca relative to controlled drugs. However, there is a bank of studies that have been designed to consider harmful chronic effects. It is therefore not possible for the Council to give a view on what could constitute a 'safe dose' due to the potential variability in the concentration of active ingredients. It is also not possible to give an indication of the volume of tea that would elicit a given level of effect.
Diversion and misuse
The likelihood of diversion is considered to be relatively low as the plants that are used to make the tea are available for purchase on the internet. In addition the tea itself is considered to have a rather unpalatable taste and so it is unlikely it will be used 'recreationally' in its imported form.
Wider implications
It should be made clear that whilst users of hoasca report positive effects from consuming the tea, its use may not be without risk of harm potentially associated with states of altered consciousness that could be induced by the tea, for example, suggestibility.
Conclusion
Hoasca is a preparation of a class A substance, DMT. In addition to the actual and/or potential harms associated with class A substances, the Council has concerns around hoasca formulation, concentration and the paucity of evidence on toxicology."